Genpharmasec Limited

ADIRASA

INE861N01036

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:58 2024-07-12 am EDT			5-day change	1st Jan Change
2.34 ^INR	+2.63%		-1.68%	-49.89%

May. 24	Genpharmasec Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI
May. 24	Genpharmasec Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI

Genpharmasec Limited Announces Resignation of Vivek Anand Oberoi as Chief Strategy Officer

February 14, 2022 at 07:37 am EST

Genpharmasec Limited announced that at its board meeting held on February 14, 2022, approved resignation of Mr. Vivek Anand Oberoi, from the post of chief strategy officer of the company, effective February 14, 2022 due to his pre-occupation in other assignments.

Latest news about Genpharmasec Limited

Genpharmasec Limited Reports Earnings Results for the Full Year Ended March 31, 2024	May. 24	CI
Genpharmasec Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	May. 24	CI
Genpharmasec Limited Announces Appointment of Hardik Makwana as Company Secretary & Compliance Officer	Mar. 27	CI
Genpharmasec Limited Announces Resignation of Heta Shah as Company Secretary / Compliance Officer	Mar. 20	CI
Genpharmasec Limited Announces Resignation of Ulhas Narayan Deosthale from the Post of Executive Director	Mar. 12	CI
Genpharmasec Limited completed the acquisition of an unknown stake in Derren Healthcare Private Limited from the existing shareholder.	Mar. 10	CI
Genpharmasec Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 12	CI
Genpharmasec Forms Subsidiary for Molecular Testing Services	Jan. 29	MT
Genpharmasec Limited Forms New Wholly Owned Subsidiary Company Namely Clinigenome India Private Limited	Jan. 29	CI
Genpharmasec Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 08	CI
Genpharmasec to Acquire 70% Stake in Derren Healthcare for INR126.4 Million	23-09-19	MT
Genpharmasec Limited signed a share purchase agreement to acquire an unknown stake in Derren Healthcare Private Limited from the existing shareholder for approximately INR 130 million.	23-09-18	CI
Genpharmasec Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-11	CI
Genpharmasec Sets Up Middle East Unit	23-07-14	MT
Genpharmasec Limited Incorporates Foreign Subsidiary Namely Genpharmasec Middle East DMCC	23-07-14	CI
Genpharmasec Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-26	CI
Genpharmasec Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-10	CI
Genpharmasec Limited Announces Board Changes	22-11-01	CI
Genpharmasec Limited Announces CFO Changes	22-11-01	CI
Genpharmasec Limited Appoints Heta Shah as Company Secretary and Compliance Officer, with Effect from October 7, 2022	22-10-07	CI
Genpharmasec Limited Announces Resignation of Amisha Mitesh Dani as Independent Director	22-10-06	CI
Genpharmasec Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-10	CI
Genpharmasec Limited Announces Executive Appointments	22-07-04	CI
Genpharmasec Limited Announces Director Resignations with Effect from June 21, 2022	22-06-21	CI
Genpharmasec Limited Announces Resignation of Independent Directors	22-06-18	CI

Chart Genpharmasec Limited

Duration

Period

More charts

Company Profile

Genpharmasec Ltd is an India-based company, which is engaged in the distribution of the lucrative medical and diagnostics device segment. It is engaged in providing technology-based medical and diagnostics devices. The Company operates through two segments: Distribution of Diagnostic Equipmentâs and Investment and trading in Securities. The Company holds rights for distribution of equipments, such as i-STAT Analyzers and its Cartridges manufactured by Abbott Point of Care, USA all over India. The Company also holds distribution rights of Sphingotec Biomarkers and Joinstar System through Rivaara Labs Private Limited.

Sector

Pharmaceuticals

Calendar

2024-07-23 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
GENPHARMASEC LIMITED	-49.89%	14.57M
ELI LILLY AND COMPANY	+60.25%	841B
NOVO NORDISK A/S	+39.42%	625B
JOHNSON & JOHNSON	-4.49%	360B
MERCK & CO., INC.	+18.30%	327B
ABBVIE INC.	+9.64%	300B
ASTRAZENECA PLC	+15.45%	242B
ROCHE HOLDING AG	+4.09%	228B
NOVARTIS AG	+18.51%	227B
AMGEN INC.	+12.87%	174B